80 participants
A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-23
- Start Date:
- 2019-01-14
- Completion:
- 2027-07-31
Conditions
- Ovarian Cancer
Interventions
- DRUG
No Results Yet